arly-and Long-Term Intravascular ltrasound and Angiographic Findings fter Bioabsorbable Magnesium Stent mplantation in Human Coronary Arteries on
暂无分享,去创建一个
F. Eberli | R. Erbel | T. Lüscher | P. Erne | J. Koolen | B. Bruyne | C. Mario | C. Ilsley | D. Böse | Waksman | M. Horrigan | ozef Bartunek | ichael Haude | ans Bonnier | J. Weissman
[1] Patrick W Serruys,et al. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial , 2008, The Lancet.
[2] K. Waldmann,et al. Efficacy and safety of absorbable metallic stents with adjunct intracoronary beta radiation in porcine coronary arteries. , 2007, Journal of interventional cardiology.
[3] Raimund Erbel,et al. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial , 2007, The Lancet.
[4] P. Serruys,et al. Two-year serial coronary angiographic and intravascular ultrasound analysis of in-stent angiographic late lumen loss and ultrasonic neointimal volume from the TAXUS II trial. , 2007, The American journal of cardiology.
[5] M. Briel,et al. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. , 2006, European heart journal.
[6] Karl-Heinz Waldmann,et al. Safety and efficacy of bioabsorbable magnesium alloy stents in porcine coronary arteries , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[7] Michael Joner,et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. , 2006, Journal of the American College of Cardiology.
[8] J. Carr,et al. Quantitative assessment of in‐stent dimensions: A comparison of 64 and 16 detector multislice computed tomography to intravascular ultrasound , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[9] Matthew H Samore,et al. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. , 2006, Journal of the American College of Cardiology.
[10] P. Serruys,et al. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. , 2006, European heart journal.
[11] Jan J Piek,et al. A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial. , 2005, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[12] G. Stone,et al. Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial. , 2005, Journal of the American College of Cardiology.
[13] P. Serruys,et al. Maintenance of Long-Term Clinical Benefit With Sirolimus-Eluting Coronary Stents: Three-Year Results of the RAVEL Trial , 2005, Circulation.
[14] Bernd Heublein,et al. Preliminary Results after Application of Absorbable Metal Stents in Patients with Critical Limb Ischemia , 2005, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.
[15] H. Eggebrecht,et al. Images in cardiology: the invisible stent: imaging of an absorbable metal stent with multislice spiral computed tomography. , 2005, Heart.
[16] Raimund Erbel,et al. Drug-eluting bioabsorbable magnesium stent. , 2004, Journal of interventional cardiology.
[17] Jeffrey W Moses,et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.
[18] N. Weissman,et al. Regional Remodeling as the Cause of Late Stent Malapposition , 2003, Circulation.
[19] A Haverich,et al. Left main coronary artery fistula exiting into the right atrium , 2003, Heart.
[20] Mary E. Russell,et al. TAXUS I: Six- and Twelve-Month Results From a Randomized, Double-Blind Trial on a Slow-Release Paclitaxel-Eluting Stent for De Novo Coronary Lesions , 2003, Circulation.
[21] C. Tracy,et al. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. , 2001, Journal of the American College of Cardiology.
[22] A. Colombo,et al. Results of coronary stenting for restenosis. , 1996, Journal of the American College of Cardiology.
[23] W Rutsch,et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. , 1994, The New England journal of medicine.
[24] Julio C. Palmaz,et al. Clinical Experience With the Palmaz‐Schatz Coronary Stent: Initial Results of a Multicenter Study , 1991, Circulation.
[25] F Joffre,et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. , 1987, The New England journal of medicine.